Skip to main content

FDA has questions about Merck's experimental chronic cough drug

The chronic cough drug was approved in Japan, where it will be marketed under the brand name Lyfnua.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.